ProfileGDS5822 / ILMN_3028637
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 87% 71% 70% 78% 69% 70% 69% 78% 78% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1317.287
GSM1276600PDAC Late Ablation Control 258.771
GSM1276601PDAC Late Ablation Control 373.670
GSM1276602PDAC Late Ablation 1105.478
GSM1276603PDAC Late Ablation 253.469
GSM1276604PDAC Late Ablation 359.170
GSM1303940PDAC Late Ablation_anti-CTLA4 14469
GSM1303941PDAC Late Ablation_anti-CTLA4 2145.978
GSM1303942PDAC Late Ablation_anti-CTLA4 3146.578